ctrl K

Watchlist Price Alert

Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.80

-0.05 (-5.88%)

At close: May 15, 2025, 10:48 AM

Xilio Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	6.34M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1.9M	1.85M	1.5M	1.06M	240K
Gross Profit	4.7M	-1.9M	-1.85M	-1.5M	-1.06M	-240K
Operating Income	-60.58M	-79.13M	-89.15M	-75.04M	-54.56M	-19.03M
Interest Income	n/a	n/a	n/a	600.00	600.00	n/a
Pretax Income	-58.24M	-76.4M	-88.22M	-75.8M	-55.22M	-17.31M
Net Income	-58.24M	-76.4M	-87.3M	-74.3M	-55.22M	-17.31M
Selling & General & Admin	24.78M	27M	29.95M	23.86M	10.65M	4.77M
Research & Development	41.21M	52.14M	59.2M	51.19M	43.91M	14.26M
Other Expenses	937K	n/a	927K	-756K	-656K	1.72M
Operating Expenses	66.93M	79.13M	89.15M	75.04M	54.56M	19.03M
Interest Expense	n/a	n/a	n/a	600K	600K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	66.93M	79.13M	89.15M	75.04M	54.56M	19.03M
Income Tax Expense	n/a	n/a	-927K	-1.5M	858.7K	68.14K
Shares Outstanding (Basic)	53.51M	27.5M	27.39M	27.36M	27.47M	27.47B
Shares Outstanding (Diluted)	53.51M	27.5M	27.39M	27.36M	27.47M	27.47B
EPS (Basic)	-1.09	-2.78	-3.19	-2.72	-2.01	-0.00
EPS (Diluted)	-1.09	-2.78	-3.19	-2.72	-2.01	-0.00
EBITDA	-56.5M	-73.8M	-85.58M	-73.7M	-53.5M	-17.07M
EBIT	-59.65M	-75.7M	-87.42M	-75.2M	-54.62M	-17.31M
Depreciation & Amortization	1.64M	1.9M	1.85M	1.5M	1.06M	240K